Pulished Date August, 2019
ID: 316
Share on
Share on

North America Transcatheter Aortic Valve Replacement (TAVR) Market By Surgery Method (Transfemoral Implantation, Transapical Implantation), Valve Frame Material (Nitinol, Stainless Steel), Valve Size (14mm To 18mm, 18mm To 22mm, & 22mm To 29mm), Valve Leaflets Material (Bovine Heart Tissue, Cow Heart Tissue), And End Users (Hospitals, Ambulatory Surgical Centres) - Market Analysis, Size, Geographic Countries Analysis, Competitive Strategies Analysis And Forecasts (2018 To 2023)

Pulished: August, 2019
ID: 316
Pages: 145

North America Transcatheter Aortic Valve Replacement (TAVR) Market Overview

Transcatheter aortic valve replacement (TAVR) is described as a minimally invasive procedure replaces the improper functioning aortic valves. TAVR offers an efficient valve replacement procedure as compared to open-heart surgery for the benefit of high-risk patients. Transcatheter heart valve replacement systems are referred to as cardiovascular devices replace the old and damaged valves. TAVR is used for the treatment of aortic valve disorders such as severe aortic stenosis, degeneration, & regurgitation. Transcatheter aortic valve replacement devices are integrated with valve frame (made of nitinol or stainless steel), valve leaflets material (made of bovine or cow heart tissue). These aortic valves are available with varied sizes (such as 14mm, 16mm, 18mm, 20mm, 22mm, & 29mm). TAVR is performed during different surgery methods such as transfemoral implantation (through the femoral artery), transapical implantation (through the apex of the heart), transaortic implantation (through the top of right chest), and transcaval implantation (through the femoral vein).

North America Transcatheter Aortic Valve Replacement (Tavr) Market Forecast Report (2018-2023)

North America transcatheter aortic valve replacement (TAVR) market is expected to reach USD 1.34 billion by 2023 from USD 0.62 billion in 2018, growing at a CAGR of 16.80% during the forecast period 2018-2023.

Increasing number patient population adopting for transcatheter heart valve therapy in the U.S., availability of reimbursement systems for TAVR procedures, growing number of clinical trials for new products by manufacturers, and rising demand for transcatheter heart valve surgery in Canada are driving the growth of transcatheter aortic valve replacement (TAVR) market in North America. However, the high cost of the transcatheter aortic valves and certain risks associated with TAVR therapy are expected to restrain the growth of transcatheter aortic valve replacement (TAVR) market in North America.

North America Transcatheter Aortic Valve Replacement Market (TAVR) Market Segmentation

North America transcatheter aortic valve replacement (TAVR) market is segmented based on surgery method, valve frame material, valve size, valve leaflets material, and end users. Based on surgery method, the market is sub-segmented as transfemoral implantation, transapical implantation, transaortic implantation, and transcaval implantation. Of these, transfemoral is estimated to command the largest share of North America transcatheter aortic valve replacement (TAVR) market by surgery method in 2018 and expected to grow at the highest CAGR during the forecast period. Based on valve frame material, the market is segmented as nitinol, stainless steel, and cobalt-chromium. Of these, nitinol segment is expected to account for the largest share of North America transcatheter aortic valve replacement (TAVR) market by valve frame material in 2018.

Transcatheter valve size market is segmented as 14mm to 18mm, 18mm to 22mm, and 22mm to 29mm. Based on valve leaflets material, the market is segmented as bovine heart tissue, cow heart tissue, and other valve leaflets material. Based on end users, the market is sub-segmented as hospitals, ambulatory surgical centers, & cardiac catheterization laboratories. Of these, hospital segment held the largest share of North America transcatheter aortic valve replacement (TAVR) market by end users in 2018.

On the basis of geographical areas, North America transcatheter aortic valve replacement (TAVR) market is segmented as U.S. and Canada. The U.S., accounted for a larger share of the North America transcatheter aortic valve replacement (TAVR) market in 2018, whereas Canada is estimated to grow at a higher CAGR during the forecast period 2018-2023.

Major Key Players:

  • Edwards Lifesciences Corporation (U.S.),
  • Medtronic, Inc. (Ireland),
  • Boston Scientific Corporation (U.S.),
  • Abbott Laboratories (U.S.),
  • St. Jude Medical Inc. (U.S.),
  • JenaValve Technology, Inc. (Germany),
  • Symetis SA (Switzerland),
  • Direct Flow Medical, Inc. (U.S.),
  • Sorin Group (Italy),
  • Meril Life Sciences India Pvt Ltd (India),
  •  Braile Biomedica (Brazil).

Reasons to Purchase North America Transcatheter Aortic Valve Replacement (Tavr) Market Report

  • Current and future North AmericaTranscatheter Aortic Valve Replacement (Tavr) Market outlook in the developed and emerging markets
  • Analysis of various perspectives of the market with the help of Porter’s five forces analysis
  • Identifying the segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in Excel)

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Introduction                                               

                5.2 Surgery Method                                       

                                5.2.1 Introduction                           

                                5.2.2 Transfemoral Implantation                              

                                5.2.3 Transapical Implantation                   

                                5.2.4 Transaortic Implantation                   

                                5.2.5 Transcaval Implantation                    

                5.3 Valve Material                                           

                                5.3.1 Introduction                           

                                5.3.2 Nitinol                       

                                5.3.3 Stainless Steel                       

                                5.3.4 Cobalt-Chromium                

                5.4 Valve Size                                    

                                5.4.1 Introduction                           

                                5.4.2 14mm to 18 mm                    

                                5.4.3 18mm to 22 mm                    

                                5.4.4 22mm to 29mm                     

                5.5 Valve Leaflets Material                                          

                                5.5.1 Introduction                           

                                5.5.2 Bovine Heart Tissue                            

                                5.5.3 Cow Heart Tissue                 

                                5.5.4 Other Valve Leaflets Material                         

                5.6 End Users                                    

                                5.6.1 Introduction                           

                                5.6.2 Hospitals                  

                                5.6.3 Ambulatory Surgical Centres                           

                                5.6.4 Cardiac Catheterization Laboratories                           

6. Geographical Analysis                                                              

                                6.1 Introduction                               

                                6.2 United States                            

                                6.3 Canada                         

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Edwards Lifesciences Corporation (U.S.)                                       

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Medtronic, Inc. (Ireland)                                      

                8.3 Boston Scientific Corporation (U.S.)                                 

                8.4 Abbott Laboratories (U.S.)                                   

                8.5 St. Jude Medical Inc. (U.S.)                                  

                8.6 JenaValve Technology, Inc. (Germany)                                          

                8.7 Symetis SA (Switzerland)                                      

                8.8 Direct Flow Medical, Inc. (U.S.)                                          

                8.9 Sorin Group (Italy)                                   

                8.10 Meril Life Sciences India Pvt Ltd (India)                                        

                8.11 Braile Biomedica (Brazil)                                     

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

 

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Transcatheter Aortic Valve Replacement Market By Region, From 2018-202 (USD Billion)
  2. North America Transcatheter Aortic Valve Replacement Market By Surgery Method, From 2018-2023 (USD Billion)
  3. North America Transfemoral Implantation Transcatheter Aortic Valve Replacement Market By Region, From 2018-2023 (USD Billion)
  4. North America Transapical Implantation Transcatheter Aortic Valve Replacement Market By Region, From 2018-2023 (USD Billion)
  5. North America Transaortic Implantation Market By Region, From 2018-2023 (USD Billion)
  6. North America Transcaval Implantation Market By Region, From 2018-2023 (USD Billion)
  7. North America Transcatheter Aortic Valve Replacement Market By Valve Frame Material, From 2018-2023 (USD Billion)
  8. North America Nitinol Transcatheter Aortic Valve Frame Material Market By Region, From 2018-2023 (USD Billion)
  9. North America Stainless Steel Transcatheter Aortic Valve Frame Material Market By Region, From 2018-2023 (USD Billion)
  10. North America Cobalt-Chromium Transcatheter Aortic Valve Frame Material Market By Region, From 2018-2023 (USD Billion)
  11. North America Transcatheter Aortic Valve Replacement Market By Valve Size, From 2018-2023 (USD Billion)
  12. North America 14mm to 18mm Transcatheter Aortic Valve Size Market By Region, From 2018-2023 (USD Billion)
  13. North America 18mm to 22mm Transcatheter Aortic Valve Size Market By Region, From 2018-2023 (USD Billion)
  14. North America 22mm to 29mm Transcatheter Aortic Valve Size Market By Region, From 2018-2023 (USD Billion)
  15. North America Transcatheter Aortic Valve Replacement Market By Valve Leaflets Material, From 2018-2023 (USD Billion)
  16. North America Bovine Heart Tissue Transcatheter Aortic Valve Leaflets Material Market By Region, From 2018-2023 (USD Billion)
  17. North America Cow Heart Tissue Transcatheter Aortic Valve Leaflets Material Market By Region, From 2018-2023 (USD Billion)
  18. North America Other Transcatheter Aortic Valve Leaflets Material Market By Region, From 2018-2023 (USD Billion)
  19. North America Transcatheter Aortic Valve Replacement Market By End Users, From 2018-2023 (USD Billion)
  20. North America Hospitals Transcatheter Aortic Valve Replacement Market By Region, From 2018-2023 (USD Billion)
  21. North America Ambulatory Surgical Centres Transcatheter Aortic Valve Replacement Market By Region, From 2018-2023 (USD Billion)
  22. North America Cardiac Catheterization Laboratories Transcatheter Aortic Valve Replacement Market By Region, From 2018-2023 (USD Billion)
  23. United States Transcatheter Aortic Valve Replacement Market By Surgery Method, From 2018-2023 (USD Billion)
  24. United States Transcatheter Aortic Valve Replacement Market By Valve Frame Material, From 2018-2023 (USD Billion)
  25. United States Transcatheter Aortic Valve Replacement Market By Valve Size, From 2018-2023 (USD Billion)
  26. United States Transcatheter Aortic Valve Replacement Market By Valve Leaflets Material, From 2018-2023 (USD Billion)
  27. United States Transcatheter Aortic Valve Replacement Market By End Users, From 2018-2023 (USD Billion)
  28. Canada Transcatheter Aortic Valve Replacement Market By Surgery Method, From 2018-2023 (USD Billion)
  29. Canada Transcatheter Aortic Valve Replacement Market By Valve Frame Material, From 2018-2023 (USD Billion)
  30. Canada Transcatheter Aortic Valve Replacement Market By Valve Size, From 2018-2023 (USD Billion)
  31. Canada Transcatheter Aortic Valve Replacement Market By Valve Leaflets Material, From 2018-2023 (USD Billion)
  32. Canada Transcatheter Aortic Valve Replacement Market By End Users, From 2018-2023 (USD Billion)

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample